BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 10346862)

  • 1. Closo-dodecaborate(2-) as a linker for iodination of macromolecules. Aspects on conjugation chemistry and biodistribution.
    Tolmachev V; Koziorowski J; Sivaev I; Lundqvist H; Carlsson J; Orlova A; Gedda L; Olsson P; Sjöberg S; Sundin A
    Bioconjug Chem; 1999; 10(3):338-45. PubMed ID: 10346862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reagents for astatination of biomolecules. 2. Conjugation of anionic boron cage pendant groups to a protein provides a method for direct labeling that is stable to in vivo deastatination.
    Wilbur DS; Chyan MK; Hamlin DK; Vessella RL; Wedge TJ; Hawthorne MF
    Bioconjug Chem; 2007; 18(4):1226-40. PubMed ID: 17583925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radio-iodination of monoclonal antibody using potassium [125I]-(4-isothiocyanatobenzylammonio)-iodo-decahydro-closo-dodecaborate (iodo-DABI).
    Orlova A; Bruskin A; Sivaev I; Sjöberg S; Lundqvist H; Tolmachev V
    Anticancer Res; 2006; 26(2A):1217-23. PubMed ID: 16619527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodistribution of the chimeric monoclonal antibody U36 radioiodinated with a closo-dodecaborate-containing linker. Comparison with other radioiodination methods.
    Nestor M; Persson M; Cheng J; Tolmachev V; van Dongen G; Anniko M; Kairemo K
    Bioconjug Chem; 2003; 14(4):805-10. PubMed ID: 12862434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo evaluation of phosphorous-containing derivatives of dodecahydro-closo-dodecaborate for boron neutron capture therapy of gliomas and sarcomas.
    Tjarks W; Barth RF; Rotaru JH; Adams DM; Yang W; Kultyshev RG; Forrester J; Barnum BA; Soloway AH; Shore SG
    Anticancer Res; 2001; 21(2A):841-6. PubMed ID: 11396173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, radioiodination, and biodistribution of some nido- and closo-monocarbon carborane derivatives.
    Wilbur DS; Hamlin DK; Srivastava RR; Chyan MK
    Nucl Med Biol; 2004 May; 31(4):523-30. PubMed ID: 15093823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting of a head and neck squamous cell carcinoma xenograft model using the chimeric monoclonal antibody U36 radioiodinated with a closo-dodecaborate-containing linker.
    Cheng J; Persson M; Tolmachev V; Siavaev I; Orlova A; Kairemo K; Anniko M
    Acta Otolaryngol; 2004 Nov; 124(9):1078-85. PubMed ID: 15513553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiobromination of monoclonal antibody using potassium [76Br] (4 isothiocyanatobenzyl-ammonio)-bromo-decahydro-closo-dodecaborate (Bromo-DABI).
    Bruskin A; Sivaev I; Persson M; Lundqvist H; Carlsson J; Sjöberg S; Tolmachev V
    Nucl Med Biol; 2004 Feb; 31(2):205-11. PubMed ID: 15013486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New functionalized mercaptoundecahydrododecaborate derivatives for potential application in boron neutron capture therapy: synthesis, characterization and dynamic visualization in cells.
    Genady AR; Ioppolo JA; Azaam MM; El-Zaria ME
    Eur J Med Chem; 2015 Mar; 93():574-83. PubMed ID: 25748122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of benzoate- and dodecaborate-based linkers for attachment of radioiodine to HER2-targeting Affibody ligand.
    Tran T; Orlova A; Sivaev I; Sandström M; Tolmachev V
    Int J Mol Med; 2007 Mar; 19(3):485-93. PubMed ID: 17273798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioiodination of protein using 2,3,5,6-tetrafluorophenyl 3-(nido-carboranyl) propionate (TCP) as a potential bi-functional linker: Synthesis and biodistribution in mice.
    Lin R; Liu N; Yang Y; Li B; Liao J; Jin J
    Appl Radiat Isot; 2009 Jan; 67(1):83-7. PubMed ID: 18755593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Terminal Mono- and Bis-Conjugates of Oligonucleotides with
    Novopashina DS; Vorobyeva MA; Lomzov AA; Silnikov VN; Venyaminova AG
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reagents for astatination of biomolecules. 5. Evaluation of hydrazone linkers in (211)At- and (125)I-labeled closo-decaborate(2-) conjugates of Fab' as a means of decreasing kidney retention.
    Wilbur DS; Chyan MK; Hamlin DK; Nguyen H; Vessella RL
    Bioconjug Chem; 2011 Jun; 22(6):1089-102. PubMed ID: 21513347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of boron cluster lipids: closo-dodecaborate as an alternative hydrophilic function of boronated liposomes for neutron capture therapy.
    Lee JD; Ueno M; Miyajima Y; Nakamura H
    Org Lett; 2007 Jan; 9(2):323-6. PubMed ID: 17217295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reagents for astatination of biomolecules. 3. Comparison of closo-decaborate(2-) and closo-dodecaborate(2-) moieties as reactive groups for labeling with astatine-211.
    Wilbur DS; Chyan MK; Hamlin DK; Perry MA
    Bioconjug Chem; 2009 Mar; 20(3):591-602. PubMed ID: 19236022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reagents for astatination of biomolecules: comparison of the in vivo distribution and stability of some radioiodinated/astatinated benzamidyl and nido-carboranyl compounds.
    Wilbur DS; Chyan MK; Hamlin DK; Kegley BB; Risler R; Pathare PM; Quinn J; Vessella RL; Foulon C; Zalutsky M; Wedge TJ; Hawthorne MF
    Bioconjug Chem; 2004; 15(1):203-23. PubMed ID: 14733601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Closomers of high boron content: synthesis, characterization, and potential application as unimolecular nanoparticle delivery vehicles for boron neutron capture therapy.
    Ma L; Hamdi J; Wong F; Hawthorne MF
    Inorg Chem; 2006 Jan; 45(1):278-85. PubMed ID: 16390066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, liposomal preparation, and in vitro toxicity of two novel dodecaborate cluster lipids for boron neutron capture therapy.
    Justus E; Awad D; Hohnholt M; Schaffran T; Edwards K; Karlsson G; Damian L; Gabel D
    Bioconjug Chem; 2007; 18(4):1287-93. PubMed ID: 17569498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maleimide-functionalized closo-dodecaborate albumin conjugates (MID-AC): Unique ligation at cysteine and lysine residues enables efficient boron delivery to tumor for neutron capture therapy.
    Kikuchi S; Kanoh D; Sato S; Sakurai Y; Suzuki M; Nakamura H
    J Control Release; 2016 Sep; 237():160-7. PubMed ID: 27422608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RGD Peptide-Conjugated Dodecaborate with the Ga-DOTA Complex: A Preliminary Study for the Development of Theranostic Agents for Boron Neutron Capture Therapy and Its Companion Diagnostics.
    Mishiro K; Imai S; Ematsu Y; Hirose K; Fuchigami T; Munekane M; Kinuya S; Ogawa K
    J Med Chem; 2022 Dec; 65(24):16741-16753. PubMed ID: 36512639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.